MAPK8 and polycystic ovary syndrome: The JNK pathway plays a critical role in the inflammation and fibrosis processes associated with PCOS, and the application of the JNK inhibitor SP600125 may offer a new therapeutic strategy for the prevention of PCOS [321, 329].